CoChat

A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg

Open access
Hoogstraten, H. J. F. Van, Smet, M. B. M. De, Renooij, Breed, Engels, Ouden‐Muller, J. W. Den, Rijk, Smit, Zwertbroek, Hop, Henegouwen, G. P. Van Berge, Schalm, Buuren, H. R. Van, REPRESENTING THE DUTCH MULTICENTRE PBC STUDY GROUP · 1998 · Alimentary Pharmacology & Therapeutics
Cited by 35

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background: Ursodeoxycholic acid (UDCA) prolongs transplantation‐free survival in primary biliary cirrhosis (PBC). However, the optimal therapeutic dose has not been established. Aim: To compare the effects of UDCA administered in daily doses of 10 vs. 20 mg/kg on symptoms, liver biochemistry and biliary UDCA enrichment. Methods: A 6‐month multicentre randomized open controlled trial was conducted to assess the effects of an increase in the dose of UDCA to 20 mg/kg/day vs. continuation of 10 mg/kg/day for patients who had not achieved biochemical normalization during treatment for at least 6 months with the 10 mg/kg dose. Clinical and laboratory evaluations were performed at entry and at 3‐month intervals. The percentage UDCA in duodenal bile was assessed at entry and at 6 months. Results: Sixty‐one patients were enrolled. No side‐effects of UDCA were observed. Within the 20 mg/kg/day group significant decreases were found for alkaline phosphatase (− 8%; P = 0.003), aspartate aminotransferase (− 11%; P = 0.01), alanine aminotransferase (− 17%; P < 0.001), γ‐glutamyl transferase␣(− 34%; P < 0.001), immunoglobulin M (− 11%; P = 0.002) and cholesterol (− 8.1%; P < 0.001). In the 10 mg/kg group none of these parameters differed significantly from baseline. No significant differences between dose groups for symptom scores or serum bilirubin were found. Biliary enrichment with UDCA increased from 37% to 46% in the 20 mg/kg group (P = 0.02) while remaining stable in the 10 mg/kg group. Conclusions: Liver biochemistry improved in PBC patients receiving UDCA 20 mg/kg/day compared to a dose of 10 mg/kg/day. Both doses were equally well tolerated. These results indicate that UDCA 10 mg/kg/day is a suboptimal dose for treating PBC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2036.1998.00395.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 42

  1. 10.1056/NEJM199611213352107 · DOI · Paper page
  2. Gershwin ME, 1995, The molecular basis of primary biliary cirrhosis: interfacing clinical medicine and wet bench research, Isr J Med Sci, 31, 22
  3. 10.1016/0002-9343(94)90187-2 · DOI
  4. 10.1002/hep.1840190512 · DOI · Paper page
  5. 10.1002/hep.1840220311 · doi:10.1002/hep.1840220311 · Paper page
  6. 10.1007/BF01536665 · DOI
  7. 10.1016/S0140-6736(87)91610-2 · DOI · Paper page
  8. 10.3109/00365529709000190 · DOI · Paper page
  9. 10.1016/S0168-8278(05)80214-4 · DOI
  10. 10.1111/j.1440-1746.1994.tb01237.x · DOI · Paper page
  11. 10.1016/0016-5085(89)91698-3 · DOI · Paper page
  12. 10.1016/0168-8278(95)80297-5 · DOI
  13. Taal BG, 1983, Clinical diagnosis of primary biliary cirrhosis: a classification based on major and minor criteria, Hepatogastroenterology, 30, 178
  14. 10.1002/bjs.1800600817 · DOI · Paper page
  15. Vonk RJ, 1986, Enterohepatic circulation in man. A simple method for the determination of duodenal bile acids, J Lipid Res, 27, 901, 10.1016/S0022-2275(20)38789-7 · doi:10.1016/s0022-2275(20)38789-7
  16. 10.1097/00005176-198504000-00021 · doi:10.1097/00005176-198504000-00021
  17. Turley SD, 1978, Re‐evaluation of the 3 alpha‐hydroxysteroid dehydrogenase assay for total bile acids in bile, J␣Lipid Res, 19, 924, 10.1016/S0022-2275(20)40709-6 · DOI · Paper page
  18. 10.1016/0009-8981(83)90070-0 · DOI · Paper page
  19. 10.1016/0005-2760(86)90044-5 · DOI
  20. Mitchell S, 1997, High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomised double‐blind, placebo‐controlled trial, Gastroenterology, 112
  21. 10.3109/00365529709007686 · DOI · Paper page
  22. 10.1002/hep.1840160412 · DOI · Paper page
  23. 10.1002/hep.1840130222 · doi:10.1002/hep.1840130222
  24. 10.1016/0016-5085(92)90162-R · DOI
  25. 10.1016/0016-5085(86)90708-0 · DOI
  26. 10.1002/hep.1840040119 · DOI
  27. 10.1016/0016-5085(91)90603-I · DOI
  28. 10.1136/gut.36.6.935 · DOI · Paper page
  29. 10.1016/S0168-8278(96)80293-5 · DOI
  30. 10.1016/S0168-8278(95)80007-7 · DOI
  31. Muraca M, 1991, A simple method for the determination of lipid composition of human bile, J Lipid Res, 32, 371, 10.1016/S0022-2275(20)42097-8 · doi:10.1016/s0022-2275(20)42097-8
  32. 10.3109/00365529309103136 · doi:10.3109/00365529309103136
  33. 10.1136/gut.31.12.1407 · doi:10.1136/gut.31.12.1407
  34. Muraca M, 1994, Routine determination of biliary lipid composition with the entero‐test, Ann Chir, 48, 197
  35. 10.1002/hep.1840140609 · DOI · Paper page
  36. Batta AK, 1993, Effect of long‐term treatment with ursodiol on clinical and biochemical features and biliary bile acid metabolism in patients with primary biliary cirrhosis, Am J Gastroenterol, 88, 691
  37. 10.1016/0016-5085(91)90602-H · DOI · Paper page
  38. 10.1097/00042737-199707000-00011 · DOI
  39. 10.1016/0306-9877(86)90137-4 · DOI · Paper page
  40. 10.1016/0016-5085(93)90653-T · DOI · Paper page
  41. 10.1016/0016-5085(94)90027-2 · DOI
  42. 10.1016/0006-2952(90)90259-N · doi:10.1016/0006-2952(90)90259-n

Cited by

See all 35

Metadata

Authors
Hoogstraten, H. J. F. V., Smet, M. B. M. D., Renooij, Breed, Engels, Ouden‐Muller, J. W. D., Rijk, Smit, Zwertbroek, Hop, Henegouwen, G. P. V. B., Schalm, Buuren, H. R. V., & REPRESENTING THE DUTCH MULTICENTRE PBC STUDY GROUP
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
1998-10
Volume
12
Issue
10
Pages
965-971
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2023786519
Cited by
35
References
5
FWCI
2.70
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg. https://app.cochat.ai/papers/10.1046/j.1365-2036.1998.00395.x
The paper
Hoogstraten, H. J. F. V., Smet, M. B. M. D., Renooij, Breed, Engels, Ouden‐Muller, J. W. D., Rijk, Smit, Zwertbroek, Hop, Henegouwen, G. P. V. B., Schalm, Buuren, H. R. V., & REPRESENTING THE DUTCH MULTICENTRE PBC STUDY GROUP. (1998). A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.1998.00395.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.